ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
alnylam
Alnylam seeks a Senior Associate Scientist to utilize expertise in bioconjugation chemistry for developing RNAi therapeutics against cancer. The role involves designing protein conjugation experiments, developing purification methods using FPLC and HPLC, and synthesizing modified oligonucleotides. This collaborative position requires working closely with chemistry, biology, and pharmacology teams to advance oncology drug discovery projects.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
27% below the average for this role
Scientist, Bioconjugation
Dyne Therapeutics
Temporary Research Associate / Scientist
iSi Environmental
Senior Scientist (Oligonucleotide Conjugation)
Amgen
Principal Scientist - RGM Chemistry
Regeneron Pharmaceuticals
Senior Scientist, Medicinal Chemistry
iSi Environmental
Scientist II, Bioconjugation Chemist
biomarin